Openness as infrastructure

First Page		Document Content
Pharmaceutical sciences Computational chemistry Pharmacology Drug discovery Cheminformatics Quantitative structure–activity relationship Drug design Matrix metalloproteinase Structure–activity relationship Chemistry Medicinal chemistry Science		Openness as infrastructure Add to Reading List Source URL: www.jcheminf.com Download Document from Source Website File Size: 1,74 MB Share Document on Facebook

	ED/MD ED/MD is one of NBD’s core structure-based drug design technologies. It has been developed in one of the most highly reputed simulation groups in Europe (M. Orozco group, Institute of Research in Biomedicine, Bar DocID: 1vpEv - View Document
	Metody dokowania ligandów Strategie projektowania leków Ligand-based drug design nieznana DocID: 1vpuL - View Document
	Int. J. Computational Biology and Drug Design, Vol. 2, No. 4, 2009 A novel swarm intelligence algorithm for finding DNA motifs Chengwei Lei and Jianhua Ruan* Department of Computer Science, DocID: 1v6tg - View Document
	Send Orders of Reprints at 614 Current Pharmaceutical Design, 2013, 19, Rejuvenating Sirtuins: The Rise of a New Family of Cancer Drug Targets DocID: 1v1vA - View Document
	The University of Siena is pleased to announce the 11th European Workshop in Drug Design and Mu.Ta.Lig. Training School A unique opportunity to learn and share knowledge about computational techniques in an exciting a DocID: 1uQlo - View Document